Non-ownership Filings
| PDS: Updated Results, VERSATILE-002 Phase 2 Trial | Sep. 16, 2024 |
| PDS Biotech: Business Update and Q2 2024 Results | Aug. 13, 2024 |
| Replacement RNS: PDS Biotech Aligns with FDA | Aug. 02, 2024 |
| PDS Biotech Aligns with FDA on Phase 3 Trial | Aug. 02, 2024 |
| Q-Bot Fundraising | Jul. 30, 2024 |
| Result of AGM | Jul. 10, 2024 |
| Notice of AGM | Jun. 18, 2024 |
Ownership Update Filings
| TR-1 | Jun. 14, 2024 |
| Director/PDMR Shareholding | Jun. 14, 2024 |
| Director/PDMR Shareholding | Nov. 13, 2023 |
| Director/PDMR Shareholding | Jun. 07, 2023 |
| Holding(s) in Company | Jun. 28, 2022 |
| Holding(s) in Company | Jun. 27, 2022 |
| Director/PDMR Shareholding | Jun. 27, 2022 |